spot_img
0.1 C
London
HomeInvestors HealthBristol Myers to report Q4 IPRD/licensing expense of $18M

Bristol Myers to report Q4 IPRD/licensing expense of $18M



Bristol Myers to report Q4 IPRD/licensing expense of $18M



Source link

latest articles

explore more

LEAVE A REPLY

Please enter your comment!
Please enter your name here